Kiwecare smart monitoring device provides early detection of infection and personalized, accurate, and efficient peritoneal dialysis treatment assessment, ensuring patient’s confidence and reducing healthcare costs.
Meet Kiwecare, an innovative Finnish med-tech start-up driven by the expertise and dedication of our CEO and Founder, Pirgit Silvast-Äikäs. During 15 years working with peritoneal dialysis patients, Pirgit has realized that the current way to evaluate peritoneal function is time-consuming both for patients and medical professionals, intense to manual work, and prone to errors. Another drawback that Pirgit has noticed is the high risk of developing infection during PD treatment, which can be life-threatening, leading to hospitalisation and unfortunately transitioning from PD to hemodialysis. Early infection screening is necessary to avoid such risk.

Partners









